|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Altachem Pharma Ltd., of Edmonton, Alberta, completed enrollment of the first group of four patients in its Phase I trial of ACP-HIP for Kaposi's sarcoma. The study is designed to test the compound in three groups of four patients each at three different doses. The company said it would report data and give an interim report from the first group late next month.
o Bio-Rad Laboratories Inc., of Hercules, Calif., sold its Hemel Hempstead, UK-based confocal microscopy business to Carl Zeiss Jena GmbH for an undisclosed amount. Carl Zeiss has a plan to bring together technological and application knowledge to provide support for modern biomedical research. Bio-Rad ...